Cardiovascular disease (CVD) risk assessment of HIV medication regimens using hematopoietic CD34+ progenitor cells

por Elzarki, Adrian Farid, Nandula, Seshagiri Rao, Awal, Hassan, Simon, Gary L., Sen, Sabyasachi
Publicado 2022

Role of Canagliflozin on function of CD34+ve endothelial progenitor cells (EPC) in patients with type 2 diabetes

por Nandula, Seshagiri Rao, Kundu, Nabanita, Awal, Hassan B., Brichacek, Beda, Fakhri, Mona, Aimalla, Nikhila, Elzarki, Adrian, Amdur, Richard L., Sen, Sabyasachi
Publicado 2021

Linagliptin, when compared to placebo, improves CD34+ve endothelial progenitor cells in type 2 diabetes subjects with chronic kidney disease taking metformin and/or insulin: a rand...

por Awal, Hassan B., Nandula, Seshagiri Rao, Domingues, Cleyton C., Dore, Fiona J., Kundu, Nabanita, Brichacek, Beda, Fakhri, Mona, Elzarki, Adrian, Ahmadi, Neeki, Safai, Shauna, Fosso, Magan, Amdur, Richard L., Sen, Sabyasachi
Publicado 2020